| First Author | Targowska-Duda KM | Year | 2013 |
| Journal | Neurosci Lett | Volume | 553 |
| Pages | 186-90 | PubMed ID | 23994392 |
| Mgi Jnum | J:201749 | Mgi Id | MGI:5515661 |
| Doi | 10.1016/j.neulet.2013.08.036 | Citation | Targowska-Duda KM, et al. (2013) Role of the nicotinic receptor beta4 subunit in the antidepressant activity of novel N,6-dimethyltricyclo[5.2.1.0(2,6)]decan-2-amine enantiomers. Neurosci Lett 553:186-90 |
| abstractText | The role of the nicotinic receptor beta4 subunit in the antidepressant activity of N,6-dimethyltricyclo[5.2.1.0(2,6)]decan-2-amine enantiomers was investigated using wild-type (beta4+/+) and knockout (beta4-/-) mice. Mice were injected (i.p.) with saline (control) or with either enantiomer (1.0mg/kg base drug) daily for the first two weeks. Forced swim tests (FST) were performed on Day 1 to determine the acute effect of each enantiomer, and on Day 7 and 14, to determine the chronic activity. To examine the remnant effects after drug treatment, a withdrawal period of two more weeks was continued with FSTs performed on Day 21 and 28. Our results indicate that: (1) the acute antidepressant effect elicited by the (S,S)-enantiomer is observed in beta4+/+ mice from both sexes, whereas the effect elicited by the (R,R)-enantiomer is only observed in male beta4+/+ mice. There is no antidepressant effect for both novel compounds on male and female beta4-/- mice, (2) the chronic antidepressant effect elicited by both enantiomers is observed in beta4+/+, but not in beta4-/-, mice from both sexes, and (3) the residual antidepressant effect mediated by each enantiomer after withdrawal was observed only in female beta4+/+ mice. Our results clearly indicate that beta4-containing AChRs are targets for the antidepressant activity of these compounds, and that this activity is gender-dependent. |
